skip to main content
Refinado por: tipo de recurso: Imagens remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hallmarks of Cancer Immunoresistance (The Lancet Oncology review article: De-novo and acquired resistance to immune checkpoint targeting. 2017;18:e731–e741)
Material Type:
Imagem
Adicionar ao Meu Espaço

Hallmarks of Cancer Immunoresistance (The Lancet Oncology review article: De-novo and acquired resistance to immune checkpoint targeting. 2017;18:e731–e741)

Syn, Nicholas

figshare 2017

Texto completo disponível

2
De-novo and acquired resistance to immune checkpoint targeting (Figure 4)
Material Type:
Imagem
Adicionar ao Meu Espaço

De-novo and acquired resistance to immune checkpoint targeting (Figure 4)

Syn, Nicholas

figshare 2017

Texto completo disponível

3
De-novo and acquired resistance to immune checkpoint targeting (The Lancet Oncology)
Material Type:
Imagem
Adicionar ao Meu Espaço

De-novo and acquired resistance to immune checkpoint targeting (The Lancet Oncology)

Syn, Nicholas

figshare 2017

Texto completo disponível

4
The Lancet Oncology: De-novo and acquired resistance to immune checkpoint targeting (Figure 3)
Material Type:
Imagem
Adicionar ao Meu Espaço

The Lancet Oncology: De-novo and acquired resistance to immune checkpoint targeting (Figure 3)

Syn, Nicholas

figshare 2017

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.